Literature DB >> 23477336

Therapeutic nanoparticles in clinics and under clinical evaluation.

Catherine A Schütz1, Lucienne Juillerat-Jeanneret, Heinz Mueller, Iseult Lynch, Michael Riediker.   

Abstract

This article reviews nanoparticulate-chemotherapeutic systems that have been developed for human therapy, considering the components of the nanoparticles, the therapeutic agents associated with the nanoparticles and the clinical indications these therapeutic nanoparticles have been developed for. In this evaluation we have put into perspective the types of nanomaterials and their therapeutic indications. We have reviewed the nanoparticulate-chemotherapeutic systems that have been published, approved and marketed and that are currently in clinical use. We have also analyzed the nanoparticulate-chemotherapeutic systems that are in clinical trials and under preclinical development.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23477336     DOI： 10.2217/nnm.13.8

Source DB:  PubMed          Journal:  Nanomedicine (Lond)        ISSN： 1743-5889            Impact factor:   5.307


  54 in total

Review 1.  The role of nanotechnology in the treatment of viral infections.

Authors:  Lavanya Singh; Hendrik G Kruger; Glenn E M Maguire; Thavendran Govender; Raveen Parboosing
Journal:  Ther Adv Infect Dis       Date:  2017-07-05

2.  The Effect of Different Types of Nanoparticles on FUS and TDP-43 Solubility and Subcellular Localization.

Authors:  Jasna Lojk; Sonja Prpar Mihevc; Vladimir Boštjan Bregar; Mojca Pavlin; Boris Rogelj
Journal:  Neurotox Res       Date:  2017-04-25       Impact factor: 3.911

3.  Counter ions and constituents combination affect DODAX : MO nanocarriers toxicity in vitro and in vivo.

Authors:  Ana Cristina Norberto Oliveira; Marisa Passos Sárria; Pedro Moreira; Joana Fernandes; Lisandra Castro; Ivo Lopes; Manuela Côrte-Real; Artur Cavaco-Paulo; Maria Elisabete Cunha Dias Real Oliveira; Andreia Castro Gomes
Journal:  Toxicol Res (Camb)       Date:  2016-06-13       Impact factor: 3.524

4.  The role of hydrophobic modification on hyaluronic acid dynamics and self-assembly.

Authors:  William M Payne; Denis Svechkarev; Alexander Kyrychenko; Aaron M Mohs
Journal:  Carbohydr Polym       Date:  2017-11-08       Impact factor: 9.381

Review 5.  Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date.

Authors:  Daniel Bobo; Kye J Robinson; Jiaul Islam; Kristofer J Thurecht; Simon R Corrie
Journal:  Pharm Res       Date:  2016-06-14       Impact factor: 4.200

6.  Long-term monitoring for nanomedicine implants and drugs.

Authors:  Michaela Kendall; Iseult Lynch
Journal:  Nat Nanotechnol       Date:  2016-03       Impact factor: 39.213

Review 7.  Targeting microbial biofilms: current and prospective therapeutic strategies.

Authors:  Hyun Koo; Raymond N Allan; Robert P Howlin; Paul Stoodley; Luanne Hall-Stoodley
Journal:  Nat Rev Microbiol       Date:  2017-09-25       Impact factor: 60.633

Review 8.  High-density lipoproteins for the systemic delivery of short interfering RNA.

Authors:  Kaylin Marie McMahon; Colby Shad Thaxton
Journal:  Expert Opin Drug Deliv       Date:  2013-12-09       Impact factor: 6.648

Review 9.  Update on current and potential nanoparticle cancer therapies.

Authors:  Jonathan S Rink; Michael P Plebanek; Sushant Tripathy; C Shad Thaxton
Journal:  Curr Opin Oncol       Date:  2013-11       Impact factor: 3.645

10.  Near-Infrared Emission CuInS/ZnS Quantum Dots: All-in-One Theranostic Nanomedicines with Intrinsic Fluorescence/Photoacoustic Imaging for Tumor Phototherapy.

Authors:  Guoxian Lv; Weisheng Guo; Wei Zhang; Tingbin Zhang; Shuyi Li; Shizhu Chen; Ahmed Shaker Eltahan; Dongliang Wang; Yuqing Wang; Jinchao Zhang; Paul C Wang; Jin Chang; Xing-Jie Liang
Journal:  ACS Nano       Date:  2016-09-20       Impact factor: 15.881
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.